Tag: Mylan
Sanofi Seeking Billions from Mylan in EpiPen Antitrust Suit
Sordid details of anticompetitive behavior alleged in court filing.
The Future of EpiPen in Light of the Mylan-Pfizer Deal
An extension to the merger is being contemplated that would consolidate all aspects of the EpiPen business under one company.
Mylan, Marketer of EpiPen, to be Combined with Pfizer’s Generics Business
Both companies are subject of a suit alleging an illegal scheme to increase sales of EpiPen.
Listen: Senator Chuck Schumer Demands Airlines Keep Stock Epinephrine Onboard
Schumer called on the FAA to lift an exemption that allows airlines to forgo keeping epinephrine onboard.
Watch: How to Use Symjepi, the Prefilled Epinephrine Syringe Now Available...
A welcome addition to the market that should help alleviate shortages.
How the Opioid Crisis Could Affect the Availability of Epinephrine
Pharma is under pressure to respond which has already resulted in one company seeking bankruptcy protection.
Epipen Supply Status Update and Extension of Expiration Dates
Tighter supplies and greater variability in pharmacy-level access will potentially continue through the summer months as seasonal demand increases.
Epinephrine Auto-Injector Companies Swept Up in 44 State Price Fixing Lawsuit
State prosecutors describe a price fixing scheme involving more than a dozen companies and as many executives responsible for sales, marketing, and pricing.
EpiPen Shortage Will Continue for Months Longer
A source at Pfizer claims the shortage will continue for an extended time.
Watch: As the EpiPen Shortage Drags On, Chicago Mom Spells Out...
"This Is Literally The Difference Between Life And Death For My Kid."
